Back
UroGen Pharma Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
41
URGN
UroGen Pharma
Last Price:
11.36
Seasonality Move:
5.08%
Sell
2
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
20.75%
Sell
41
UroGen Pharma (URGN)
is a Sell
Is UroGen Pharma a Buy, Sell or Hold?
- The current UroGen Pharma [URGN] share price is $11.35. The Score for URGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- URGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.97. The Score for AGIO is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
URGN Stock Price Chart
What is UroGen Pharma's stock price today?
-
The UroGen Pharma share price today is $11.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight buying pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
URGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 37.94 | Sell |
Chaikin Money Flow: | 79582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.48 - 12.56) | Sell |
Bollinger Bands (100): | (11.86 - 14.56) | Sell |
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.2 | Sell |
Relative Strength Index (14 RSI): | 28.25 | Sell |
Chaikin Money Flow: | 740295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.22 - 61.14) | Sell |
Bollinger Bands (100): | (41.85 - 53.15) | Sell |
URGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.93 | Sell |
20-day SMA: | 11.96 | Sell |
50-day SMA: | 12.18 | Sell |
200-day SMA: | 14.12 | Sell |
8-day EMA: | 11.8 | Sell |
20-day EMA: | 12.01 | Sell |
50-day EMA: | 12.35 | Sell |
200-day EMA: | 13.58 | Sell |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.4 | Sell |
20-day SMA: | 53.73 | Sell |
50-day SMA: | 49.6 | Sell |
200-day SMA: | 41.93 | Sell |
8-day EMA: | 46.69 | Sell |
20-day EMA: | 51.08 | Sell |
50-day EMA: | 50.45 | Sell |
200-day EMA: | 42.79 | Sell |
UroGen Pharma Earnings Growth & URGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
UroGen Pharma Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agios Pharmaceuticals Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |